Health Condition 1: E08-E13- Diabetes mellitus Health Condition 2: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Proper written informed consent obtained from the patient before any procedure is being performed. 2.Male or female Type 2 DM patients on oral hypoglycemic agents, in the age group of 18-45 years. 3.Patient should have not participated in any other clinical trial during the past 3 months.
Exclusion criteria
Exclusion criteria: 1.Patient who are unable to consume solid and liquid orals. 2.Patients who are having complications of Diabetes mellitus and suffering from other co morbid conditions. 3.Patients who are unable to sign informed consent. 4.Patient unwilling or unable to comply with study procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage Change in the blood sugar levels before and after interventionTimepoint: DAY 0 day 1 day 3 day 6 and Day 7 | — |
Secondary
| Measure | Time frame |
|---|---|
| monitoring of adverse drug reactionsTimepoint: DAY 0 day 1 day 3 day 6 and Day 7 | — |
Countries
India
Contacts
MMC, Chennai